Charles Matine

Currently holds a position at Bionik Laboratories Corp

Position	Company	Period
Independent Director	Bionik Laboratories Corp	Aug. 1, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-06-21	2023-06-09	Bionik Laboratories Corp (BNKL)	B Purchase	24,811 -26.0% 384.75 US$649,354	24,811 -26.0%	384.75	US$649,354